Aquamin® as an Adjuvant Intervention for Ulcerative Colitis In Remission
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Colitis, Colitis, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 3/21/2019 |
| Start Date: | April 2019 |
| End Date: | March 2022 |
| Contact: | Muhammad Nadeem Aslam |
| Email: | mnaslam@umich.edu |
| Phone: | 734-936-1897 |
Aquamin®, a Multi-mineral Natural Product From Red Marine Algae, as an Adjuvant Intervention for Ulcerative Colitis in Remission
The purpose of this study is to determine if Aquamin® works as a potential treatment to
improve symptoms and if it will extend remission in patients with stable Ulcerative Colitis.
improve symptoms and if it will extend remission in patients with stable Ulcerative Colitis.
Inclusion Criteria:
- Ulcerative colitis with confirmed diagnosis by histology and endoscopy AND in stable
remission for 3 months or more without therapy or with a maintenance therapy (except
steroids and antibiotics for 3 months)
- A negative pregnancy test
Exclusion Criteria:
- No history or diagnosis of any of the following conditions: Chron's disease, bleeding
disorders, gastrointestinal or colonic malignancy, Kidney disease, including kidney
"stones" or hypercalcemia, Coagulopathy/hereditary hemorrhagic disorders/ or receiving
therapeutic doses of Coumadin or heparin.
- Ingested certain medications (Calcium, Vitamin D, fiber supplements and Non-steroidal
anti-inflammatory drugs - NSAIDs) within 30 days of study start.
We found this trial at
1
site
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials
